PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPA...

por Kolodny, Scott, Vredenburg, Michael, Zhang, Jessica, Jamieson, Brian
Publicado 2023

Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

por Mladsi, Deirdre, Barnett, Christine, Aggarwal, Kavita, Vredenburg, Michael, Dieterich, Douglas, Kim, Ray
Publicado 2020

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

por Al‐Samkari, Hanny, Jiang, Debbie, Gernsheimer, Terry, Liebman, Howard, Lee, Susie, Wojdyla, Matthew, Vredenburg, Michael, Cuker, Adam
Publicado 2022

Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study

por Oladapo, Abiola, Kolodny, Scott, Vredenburg, Michael, Swallow, Elyse, Goldschmidt, Debbie, Sarathy, Kirthana, Lopez, Priscilla, Maitland, Hillary, Yee, John
Publicado 2023

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

por Al-Samkari, Hanny, Jiang, Debbie, Gernsheimer, Terry, Liebman, Howard, Lee, Susie, Bernheisel, Chelsea, Wojdyla, Matthew, Vredenburg, Michael, Cuker, Adam
Publicado 2023

Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis

por Wojciechowski, Piotr, Wilson, Koo, Nazir, Jameel, Pustułka, Iwona, Tytuła, Anna, Smela, Beata, Pochopien, Michał, Vredenburg, Michael, McCrae, Keith R., Jurczak, Wojciech
Publicado 2021